| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |